ALUR Stock Summary and Trading Ideas (Allurion Technologies | NYSE:ALUR)

Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

Allurion Technologies trades on the NYSE stock market under the symbol ALUR.

As of December 24, 2025, ALUR stock price climbed to $1.39 with 27,682 million shares trading.

ALUR has a beta of 2.93, meaning it tends to be more sensitive to market movements. ALUR has a correlation of 0.09 to the broad based SPY ETF.

ALUR has a market cap of $17.04 million. This is considered a Sub-Micro Cap stock.

Last quarter Allurion Technologies reported $3 million in Revenue and -$1.18 earnings per share. This beat revenue expectation by $608,000 and exceeded earnings estimates by $.56.

The top ETF exchange traded funds that ALUR belongs to (by Net Assets): VXF.

ALUR has underperformed the market in the last year with a price return of -84.0% while the SPY ETF gained +17.3%. ALUR has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -35.6% and -19.7%, respectively, while the SPY returned +4.4% and +1.4%, respectively.

ALUR support price is $1.26 and resistance is $1.50 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ALUR shares will trade within this expected range on the day.